These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15805266)

  • 1. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells.
    Xiong Y; Dowdy SC; Podratz KC; Jin F; Attewell JR; Eberhardt NL; Jiang SW
    Cancer Res; 2005 Apr; 65(7):2684-9. PubMed ID: 15805266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.
    Liu N; Zhao LJ; Li XP; Wang JL; Chai GL; Wei LH
    Chin Med J (Engl); 2012 Sep; 125(18):3273-8. PubMed ID: 22964322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells.
    Januchowski R; Dabrowski M; Ofori H; Jagodzinski PP
    Cancer Lett; 2007 Feb; 246(1-2):313-7. PubMed ID: 16624484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines.
    Xiong Y; Dowdy SC; Gonzalez Bosquet J; Zhao Y; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Oct; 99(1):135-41. PubMed ID: 16024066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
    Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
    Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
    Liu Z; Marquez M; Nilsson S; Holmberg AR
    Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.
    Xu S; Ren J; Chen HB; Wang Y; Liu Q; Zhang R; Jiang SW; Li J
    Curr Pharm Des; 2014; 20(11):1881-7. PubMed ID: 23888960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
    Ikehata M; Ueda K; Iwakawa S
    Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation characteristics and developmental potential of Guangxi Bama minipig (Sus scrofa domestica) cloned embryos from donor cells treated with trichostatin A and 5-aza-2'-deoxycytidine.
    Ning SF; Li QY; Liang MM; Yang XG; Xu HY; Lu YQ; Lu SS; Lu KH
    Zygote; 2013 May; 21(2):178-86. PubMed ID: 22355002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells.
    Zhu X; Mao X; Hurren R; Schimmer AD; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3610-7. PubMed ID: 18544619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation.
    Weisenberger DJ; Velicescu M; Cheng JC; Gonzales FA; Liang G; Jones PA
    Mol Cancer Res; 2004 Jan; 2(1):62-72. PubMed ID: 14757847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
    Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
    Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
    Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications affect Dnmt3L expression.
    Aapola U; Mäenpää K; Kaipia A; Peterson P
    Biochem J; 2004 Jun; 380(Pt 3):705-13. PubMed ID: 15015937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
    Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.